Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Int J Clin Oncol. 2018 Dec;23(6):1029-1037. doi: 10.1007/s10147-018-1314-3. Epub 2018 Jul 5.
The purpose was to compare survival differences between patients with external auditory canal (EAC) cancer treated according to the University of Pittsburgh modified TNM staging system and those treated in accordance with the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual on the TNM staging system for cutaneous cancers of the head and neck.
We performed a retrospective, single-institution review of 60 patients with EAC cancer treated with curative intent between September 2002 and March 2018. Survival outcomes were measured on the basis of the two staging systems.
The C-index values for the overall survival (OS) rate revealed that the University of Pittsburgh staging system had higher prognostic accuracy than the 8th edition of the AJCC staging system. Univariable and multivariable analysis showed that T classification according to the University of Pittsburgh staging system was an independent predictor of the OS rate (hazard ratio 5.25; 95% confidence interval 1.38-24.9; P = 0.015). Meanwhile, the AJCC staging system could not differentiate T2 from T3-4 cancers.
The University of Pittsburgh staging system for patients with EAC cancer is a valuable tool for use in clinical decision-making and predicting survival outcome.
本研究旨在比较根据匹兹堡大学改良 TNM 分期系统和第 8 版美国癌症联合委员会(AJCC)头颈部皮肤癌 TNM 分期系统治疗外耳道癌(EAC)患者的生存差异。
我们对 2002 年 9 月至 2018 年 3 月期间接受根治性治疗的 60 例 EAC 患者进行了回顾性单机构研究。根据两种分期系统测量生存结局。
总生存率(OS)的 C 指数值表明,匹兹堡分期系统比第 8 版 AJCC 分期系统具有更高的预后准确性。单变量和多变量分析表明,根据匹兹堡分期系统的 T 分类是 OS 率的独立预测因子(风险比 5.25;95%置信区间 1.38-24.9;P=0.015)。同时,AJCC 分期系统无法区分 T2 期和 T3-4 期癌症。
对于 EAC 患者,匹兹堡大学分期系统是用于临床决策和预测生存结果的有价值的工具。